Stocks in Switzerland Advance as Richemont, Novartis Gain

Swiss stocks rose, posting their second-biggest gain this year, as Cie. Financiere Richemont SA reported profit that beat forecasts and Novartis AG said its lung-disease drug met its objective in a study.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.